[Association Between Serum BIN1 Level and Killip Class in Patients with Acute Myocardial Infraction]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2024 Dec 26

PMID 39725628

Authors

Yanni Wang

Xia Huang

Fuheng Chen

Yuanyuan Gao

Xiangrong Cui

Qin Yan

Xuan Jing

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the correlation of serum levels of bridging integrating factor 1 (BIN1) with acute myocardial infarction (AMI) and Killip class of the patients.

Methods: We retrospectively collected the data from 94 patients with AMI and 30 healthy individuals for analysis of the correlations of serum BIN1 levels with Killip class, TIMI scores, and neutrophil-to-lymphocyte ratio (NLR). We also assessed the diagnostic value of BIN1 combined with NLR for AMI.

Results: Serum BIN1 levels were significantly lower in AMI patients than in the healthy individuals (=0.032). The AMI patients with Killip class I had significantly lower serum BIN1 levels than the healthy individuals (=0.008). Serum BIN1 level was an independent predictor of AMI with a predictive value of 0.630 (95% : 0.513-0.748) at the optimal cutoff level of 0.341 ng/mL, a specificity of 50%, and a sensitivity of 78.5%. Serum BIN1 level was also an independent predictor for Killip class I group in the AMI patients with a predictive value of 0.672 (95% : 0.548-0.797) at the optimal cutoff level of 0.287 ng/mL, a specificity of 74.1%, and a sensitivity of 60%. For AMI diagnosis, the combination of NLR and serum BIN1 level had a predictive value of 0.811 (95% : 0.727-0.895) at the optimal cutoff level of 0.548 ng/mL, with a specificity of 92.6% and a sensitivity of 62.2%. There was a positive correlation between serum BIN1 level and TIMI score in AMI patients (=0.186, =0.003).

Conclusions: BIN1 is correlated with AMI and can be helpful for predicting short-term prognosis of the patients, and BIN1 combined with NLR has a high diagnostic value for AMI.

References

Zhang Y, Jiao L, Sun L, Li Y, Gao Y, Xu C . LncRNA as a SERCA2a Inhibitor to Cause Intracellular Ca Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction. Circ Res. 2018; 122(10):1354-1368. PMC: 5959220. DOI: 10.1161/CIRCRESAHA.117.312117. View

Jiang X, Zhu Y, Liu H, Chen S, Zhang D . Effect of BIN1 on cardiac dysfunction and malignant arrhythmias. Acta Physiol (Oxf). 2019; 228(3):e13429. DOI: 10.1111/apha.13429. View

Zhou K, Hong T . Cardiac BIN1 (cBIN1) is a regulator of cardiac contractile function and an emerging biomarker of heart muscle health. Sci China Life Sci. 2016; 60(3):257-263. DOI: 10.1007/s11427-016-0249-x. View

Kikuchi M, Tahara Y, Yamaguchi J, Nakashima T, Nomura O, Tanaka A . Executive Summary　- Acute Coronary Syndrome in the Japan Resuscitation Council Guidelines for Resuscitation 2020. Circ J. 2023; 87(6):866-878. DOI: 10.1253/circj.CJ-23-0096. View

Li J, Richmond B, Hong T . Cardiac T-Tubule cBIN1-Microdomain, a Diagnostic Marker and Therapeutic Target of Heart Failure. Int J Mol Sci. 2021; 22(5). PMC: 7956774. DOI: 10.3390/ijms22052299. View

Mackrill J . Evolution of the cardiac dyad. Philos Trans R Soc Lond B Biol Sci. 2022; 377(1864):20210329. PMC: 9527923. DOI: 10.1098/rstb.2021.0329. View

North B, Sinclair D . The intersection between aging and cardiovascular disease. Circ Res. 2012; 110(8):1097-108. PMC: 3366686. DOI: 10.1161/CIRCRESAHA.111.246876. View

Milwidsky A, Greidinger D, Frydman S, Hochstadt A, Ifrach-Kashtan N, Mizrachi M . Echocardiographic Killip Classification. J Am Soc Echocardiogr. 2021; 35(3):287-294. DOI: 10.1016/j.echo.2021.10.012. View

Kala P . Thrombolysis in ST-elevation myocardial infarction is not dead. EuroIntervention. 2021; 16(14):1129-1130. PMC: 9707431. DOI: 10.4244/EIJV16I14A203. View

10.

Garibaldi M, Bohm J, Fattori F, Koch C, Surace C, Ottaviani P . Novel Dominant Mutation in BIN1 Gene Causing Mild Centronuclear Myopathy Revealed by Myalgias and CK Elevation. J Neuromuscul Dis. 2016; 3(1):111-114. DOI: 10.3233/JND-150125. View

11.

Diaz-Vesga M, Flores-Vergara R, Riquelme J, Llancaqueo M, Sanchez G, Vergara C . Polycystin-1 Is a Crucial Regulator of BIN1 Expression and T-Tubule Remodeling Associated with the Development of Dilated Cardiomyopathy. Int J Mol Sci. 2023; 24(1). PMC: 9820588. DOI: 10.3390/ijms24010667. View

12.

Dibb K, Louch W, Trafford A . Cardiac Transverse Tubules in Physiology and Heart Failure. Annu Rev Physiol. 2021; 84:229-255. DOI: 10.1146/annurev-physiol-061121-040148. View

13.

Kalayinia S, Arjmand F, Maleki M, Malakootian M, Singh C . MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol. 2020; 50:107296. DOI: 10.1016/j.carpath.2020.107296. View

14.

Hong T, Yang H, Zhang S, Cho H, Kalashnikova M, Sun B . Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat Med. 2014; 20(6):624-32. PMC: 4048325. DOI: 10.1038/nm.3543. View

15.

Lin J, Wang X, Zhai S, Shi M, Peng C, Deng X . Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1. J Hematol Oncol. 2022; 15(1):128. PMC: 9450374. DOI: 10.1186/s13045-022-01348-7. View

16.

Ye X, Zhang P, Zhang Y, Luan J, Xu C, Wu Z . GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis. Front Immunol. 2022; 13:893914. PMC: 9546776. DOI: 10.3389/fimmu.2022.893914. View

17.

Sudwarts A, Ramesha S, Gao T, Ponnusamy M, Wang S, Hansen M . BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia. Mol Neurodegener. 2022; 17(1):33. PMC: 9077874. DOI: 10.1186/s13024-022-00535-x. View

18.

Gambardella J, Wang X, Ferrara J, Morelli M, Santulli G . Cardiac BIN1 Replacement Therapy Ameliorates Inotropy and Lusitropy in Heart Failure by Regulating Calcium Handling. JACC Basic Transl Sci. 2020; 5(6):579-581. PMC: 7315227. DOI: 10.1016/j.jacbts.2020.03.018. View

19.

Laury-Kleintop L, Mulgrew J, Heletz I, Nedelcoviciu R, Young Chang M, Harris D . Cardiac-specific disruption of Bin1 in mice enables a model of stress- and age-associated dilated cardiomyopathy. J Cell Biochem. 2015; 116(11):2541-51. DOI: 10.1002/jcb.25198. View

20.

Ridker P, Rane M . Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease. Circ Res. 2021; 128(11):1728-1746. DOI: 10.1161/CIRCRESAHA.121.319077. View